SB-743921

DB05546InvestigationalSmall molecule

Investigated for use/treatment in cancer/tumors (unspecified) and lymphoma (non-hodgkin's).

Chemical structure of SB-743921
Primary indication
Investigated for use/treatment in cancer/tumors (unspecified) and lymphoma (non-hodgkin's).Curator reviewed
Formula / weight
C31H33ClN2O3 · 517.07 g/mol (avg)
Code names
SB-743921 · SB-743921 free base

Resolves to

Compound
UNII24DSZ1VN92CAS618430-39-0ChEMBLCHEMBL2325429
Structure
InChIKeyPGXYIBJJCLWJST-MUUNZHRXSA-NSMILESCC(C)[C@@H](N(CCCN)C(=O)C1=CC=C(C)C=C1)C1=C(CC2=CC=CC=C2)C(=O)C2=CC=C(Cl)C=C2O1
Targets
P52732KIF11

What you can answer from here — as of February 04, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with SB-743921, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In